OSM and arthritic joint disease: [35]. OA, a symmetric polyarthritis, impairs joints–e.g., meta-carpaphalangeal, proximal, interphalangeal–resulting in cartilage destruction [36]. Since OSM is constitutively expressed in the bone compartment and detected in patients with arthritis pathology [23], using OSM antibody could decrease cartilage destruction of knee joints invivo[37].